Further hearing loss during osteoporosis treatment with etidronate.

Ototoxicity is a rare and disabling complication in bisphosphonate therapy. Here we describe two patients who encountered further hearing loss during oral etidronate treatment for osteoporosis.

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Yaşil, S., Cömlekçi, A., Güneri, A.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Group 1998
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2360958/
https://ncbi.nlm.nih.gov/pubmed/9799894
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia